A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs.
Pharmacy world & science : PWS April 1, 2004 Douwe De Boer, Ingrid Bosman 89 citations
Between 1994 and 2002, products sold in Dutch smartshops as synthetic drugs were purchased and analyzed. Most tablets contained one of the phenethylamine designer drugs 2C-B, 2C-T-2, or 2C-T-7, with new drugs appearing on the market roughly every three years. Accompanying leaflets provided extensive but partly misleading information. Scientific data on health risks and detection of these 2C-series drugs was scarce. No intoxications had been reported in the European Union, and no centralized legal actions had been taken. The absence of observed intoxications may justify the lack of EU legal actions, but could also reflect toxicologists' inability to detect these substances or unawareness of the phenomenon. EU authorities should promote availability of standards, validated assays, and scientific knowledge.